In response to significant portfolio depreciation, Oxford Lane Capital has announced a strategic move to stabilize its financial position. The company confirmed plans yesterday to issue a new series of preferred shares, a direct measure aimed at addressing a challenging quarter that saw a severe decline in its net asset value.
Market Pressures Trigger Strategic Shift
The decision follows a period of substantial pressure on Oxford Lane Capital’s core investments. The firm, which primarily allocates capital to collateralized loan obligations (CLOs), witnessed a sharp contraction in its net asset value per share. By the end of the 2025 fiscal year, this key metric had fallen to $15.51 from $19.19. This decline was primarily driven by approximately $305.4 million in unrealized depreciation within its investment portfolio, reflecting recent downward market revaluations of CLO assets.
Despite generating net investment income of $71.8 million in the final quarter, the company’s overall net assets contracted by more than $240 million. This erosion has prompted management to take corrective action to adjust the firm’s capital structure.
Terms of the Proposed Offering
The financing will be raised through the issuance of “Series 2031 Term Preferred Shares.” These securities carry a liquidation preference of $25 per share and provide a fixed, cumulative monthly dividend. A mandatory redemption is scheduled for the year 2031. Final terms, including the offering price, are currently being negotiated with an underwriting syndicate led by Lucid Capital Markets and Piper Sandler. Management intends to use the net proceeds to repay existing debt obligations and bolster general working capital.
Should investors sell immediately? Or is it worth buying Oxford Lane Capital?
A Challenging Financial Landscape
Oxford Lane Capital’s current market standing underscores the urgency of this capital raise. The stock is trading near its 52-week low of $8.20, having declined 40.5% over the past six months. An extremely high dividend yield, currently quoted above 27%, is largely a function of this pronounced share price depreciation rather than a signal of sustainable income.
Further highlighting a tight liquidity position, the company’s current ratio stands at a constrained 0.61. The planned listing of the new preferred shares on the NASDAQ Global Select Market is expected within the next 30 days. The success of this offering is seen as heavily dependent on final pricing achieved in the current credit environment.
This strategic issuance represents an effort by Oxford Lane Capital to realign its leverage in direct response to shifting valuations across the CLO sector.
Ad
Oxford Lane Capital Stock: Buy or Sell?! New Oxford Lane Capital Analysis from March 24 delivers the answer:
The latest Oxford Lane Capital figures speak for themselves: Urgent action needed for Oxford Lane Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 24.
Oxford Lane Capital: Buy or sell? Read more here...









